According to Zoetis's latest financial reports the company's total debt is $6.75 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $6.75 B | -16.5% |
2022-12-31 | $8.09 B | 19.98% |
2021-12-31 | $6.74 B | -8.41% |
2020-12-31 | $7.36 B | 11.36% |
2019-12-31 | $6.61 B | 2.46% |
2018-12-31 | $6.45 B | 30.26% |
2017-12-31 | $4.95 B | 10.85% |
2016-12-31 | $4.46 B | -8.22% |
2015-12-31 | $4.86 B | 34.07% |
2014-12-31 | $3.63 B | -0.71% |
2013-12-31 | $3.65 B | 528.35% |
2012-12-31 | $0.58 B | 1.22% |
2011-12-31 | $0.57 B | -19.13% |
2010-12-31 | $0.71 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $70.84 B | 948.78% | ๐บ๐ธ USA |
Eli Lilly LLY | $25.22 B | 273.43% | ๐บ๐ธ USA |
Sanofi SNY | $20.36 B | 201.51% | ๐ซ๐ท France |
Merck MRK | $35.05 B | 418.95% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | $0.51 B | -92.40% | ๐บ๐ธ USA |
Kindred Biosciences
KIN | N/A | N/A | ๐บ๐ธ USA |
Heska Corporation
HSKA | $0.10 B | -98.38% | ๐บ๐ธ USA |